ESSA Pharma Inc
NASDAQ:EPIX

Watchlist Manager
ESSA Pharma Inc Logo
ESSA Pharma Inc
NASDAQ:EPIX
Watchlist
Price: 1.63 USD 1.87% Market Closed
Market Cap: 72.4m USD
Have any thoughts about
ESSA Pharma Inc?
Write Note

Intrinsic Value

EPIX's intrinsic value estimate is unreliable because it is based only on its DCF value and doesn't use a relative valuation using multiples.

The intrinsic value of one EPIX stock under the Base Case scenario is 8.86 USD. Compared to the current market price of 1.63 USD, ESSA Pharma Inc is Undervalued by 82%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

EPIX Intrinsic Value
8.86 USD
Undervaluation 82%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
ESSA Pharma Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Valuation History Unavailable

Historical valuation for EPIX cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about EPIX?
Bearish
Neutral
Bullish

Fundamental Analysis

1.63 USD
+1.87%
+1.87%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

ESSA Pharma Inc
CA
Biotechnology
Market Cap
72.4m USD
IPO
-
Employees
30
Canada
Market Cap
72.4m USD
Industry
Biotechnology
IPO
-
Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about ESSA Pharma Inc

Provide an overview of the primary business activities
of ESSA Pharma Inc.

What unique competitive advantages
does ESSA Pharma Inc hold over its rivals?

What risks and challenges
does ESSA Pharma Inc face in the near future?

Has there been any significant insider trading activity
in ESSA Pharma Inc recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for ESSA Pharma Inc.

Provide P/S
for ESSA Pharma Inc.

Provide P/E
for ESSA Pharma Inc.

Provide P/OCF
for ESSA Pharma Inc.

Provide P/FCFE
for ESSA Pharma Inc.

Provide P/B
for ESSA Pharma Inc.

Provide EV/S
for ESSA Pharma Inc.

Provide EV/GP
for ESSA Pharma Inc.

Provide EV/EBITDA
for ESSA Pharma Inc.

Provide EV/EBIT
for ESSA Pharma Inc.

Provide EV/OCF
for ESSA Pharma Inc.

Provide EV/FCFF
for ESSA Pharma Inc.

Provide EV/IC
for ESSA Pharma Inc.

Show me price targets
for ESSA Pharma Inc made by professional analysts.

What are the Revenue projections
for ESSA Pharma Inc?

How accurate were the past Revenue estimates
for ESSA Pharma Inc?

What are the Net Income projections
for ESSA Pharma Inc?

How accurate were the past Net Income estimates
for ESSA Pharma Inc?

What are the EPS projections
for ESSA Pharma Inc?

How accurate were the past EPS estimates
for ESSA Pharma Inc?

What are the EBIT projections
for ESSA Pharma Inc?

How accurate were the past EBIT estimates
for ESSA Pharma Inc?

Compare the revenue forecasts
for ESSA Pharma Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of ESSA Pharma Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of ESSA Pharma Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of ESSA Pharma Inc compared to its peers.

Compare the P/E ratios
of ESSA Pharma Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing ESSA Pharma Inc with its peers.

Analyze the financial leverage
of ESSA Pharma Inc compared to its main competitors.

Show all profitability ratios
for ESSA Pharma Inc.

Provide ROE
for ESSA Pharma Inc.

Provide ROA
for ESSA Pharma Inc.

Provide ROIC
for ESSA Pharma Inc.

Provide ROCE
for ESSA Pharma Inc.

Provide Gross Margin
for ESSA Pharma Inc.

Provide Operating Margin
for ESSA Pharma Inc.

Provide Net Margin
for ESSA Pharma Inc.

Provide FCF Margin
for ESSA Pharma Inc.

Show all solvency ratios
for ESSA Pharma Inc.

Provide D/E Ratio
for ESSA Pharma Inc.

Provide D/A Ratio
for ESSA Pharma Inc.

Provide Interest Coverage Ratio
for ESSA Pharma Inc.

Provide Altman Z-Score Ratio
for ESSA Pharma Inc.

Provide Quick Ratio
for ESSA Pharma Inc.

Provide Current Ratio
for ESSA Pharma Inc.

Provide Cash Ratio
for ESSA Pharma Inc.

What is the historical Revenue growth
over the last 5 years for ESSA Pharma Inc?

What is the historical Net Income growth
over the last 5 years for ESSA Pharma Inc?

What is the current Free Cash Flow
of ESSA Pharma Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for ESSA Pharma Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
ESSA Pharma Inc

Current Assets 127.6m
Cash & Short-Term Investments 126.8m
Receivables 163k
Other Current Assets 636.5k
Non-Current Assets 552.4k
PP&E 295.5k
Other Non-Current Assets 257k
Current Liabilities 3.3m
Accounts Payable 2.4m
Accrued Liabilities 897.5k
Non-Current Liabilities 205.2k
Other Non-Current Liabilities 205.2k
Efficiency

Earnings Waterfall
ESSA Pharma Inc

Revenue
0 USD
Cost of Revenue
-99.2k USD
Gross Profit
-99.2k USD
Operating Expenses
-34.3m USD
Operating Income
-34.4m USD
Other Expenses
5.9m USD
Net Income
-28.5m USD

Free Cash Flow Analysis
ESSA Pharma Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

EPIX Profitability Score
Profitability Due Diligence

ESSA Pharma Inc's profitability score is 34/100. The higher the profitability score, the more profitable the company is.

34/100
Profitability
Score

ESSA Pharma Inc's profitability score is 34/100. The higher the profitability score, the more profitable the company is.

EPIX Solvency Score
Solvency Due Diligence

ESSA Pharma Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

ESSA Pharma Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

EPIX Price Targets Summary
ESSA Pharma Inc

There are no price targets for EPIX.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for EPIX?

Click here to dive deeper.

Dividends

ESSA Pharma Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for EPIX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

EPIX Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

See Also

Discover More
What is the Intrinsic Value of one EPIX stock?

The intrinsic value of one EPIX stock under the Base Case scenario is 8.86 USD.

Is EPIX stock undervalued or overvalued?

Compared to the current market price of 1.63 USD, ESSA Pharma Inc is Undervalued by 82%.

Back to Top